WALTHAM, Mass.--(BUSINESS WIRE)--Entasis Therapeutics, a company leveraging its expertise and a unique pathogen-targeted approach to develop and advance novel antibacterials, today announced the appointment of Robin David Isaacs, M.D., as Chief Medical Officer. Dr. Isaacs has extensive experience as a pharmaceutical executive in the development and launch of vaccine and infectious disease products.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
